Journal Retracts 2023 Study on Cetuximab-Loaded Albumin Nanoparticles for Colon Cancer Cells
The Editor-in-Chief of Cancer Nanotechnology has retracted a 2023 paper on cetuximab-loaded egg serum albumin nanoparticles after concerns about figures ...
The Editor-in-Chief of Cancer Nanotechnology has retracted a 2023 paper on cetuximab-loaded egg serum albumin nanoparticles after concerns about figures ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.